Аннотация
Vitiligo is a chronic skin disease characterized by depigmentation resulting from the destruction of melanocytes. One promising therapeutic approach is the use of fluorouracil, an antimetabolite with immunomodulatory and cytotoxic properties. The aim of this study is to evaluate the effectiveness of different fluorouracil treatment regimens in stable non-segmental vitiligo. Vitiligo affects approximately 1% of the population, and its etiology remains unclear, involving autoimmune, genetic, and external factors. Fluorouracil is traditionally used in oncology, but its ability to induce repigmentation makes it a potential candidate for the treatment of vitiligo. The aim of this study is to compare the effectiveness of different fluorouracil treatment regimens in patients with stable non-segmental vitiligo.
Ключевые слова
—